Dr Ralph Kern
BrainStorm Cell Therapeutics
"NurOwn ALS Phase 3 clinical trial update" (co-presenter)
Ralph Kern MD MHSc is President and Chief Medical Officer of BrainStorm Cell Therapeutics. His industry experience includes senior executive roles at Biogen, Novartis and Genzyme.
Prior to joining industry, he was head of the post graduate academic neurology program at the University of Toronto. He completed neurology training at McGill University and the University College London, fellowship training in neuromuscular disease, and completed the MHSc program in Health Administration from the Institute of Health Policy Management and Evaluation at the Dalla Lana School of Public Health at the University of Toronto.